| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Clinical applications of magnetic nanoparticles for hyperthermia.
|
Int J Hyperthermia
|
2008
|
2.32
|
|
2
|
Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme.
|
J Neurooncol
|
2006
|
2.22
|
|
3
|
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme.
|
J Neurooncol
|
2010
|
2.02
|
|
4
|
Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution.
|
Eur Urol
|
2006
|
2.00
|
|
5
|
Magnetic nanoparticles for interstitial thermotherapy--feasibility, tolerance and achieved temperatures.
|
Int J Hyperthermia
|
2006
|
1.50
|
|
6
|
Magnetic nanoparticle hyperthermia for prostate cancer.
|
Int J Hyperthermia
|
2010
|
1.50
|
|
7
|
Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermia.
|
Med Phys
|
2004
|
1.26
|
|
8
|
Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer.
|
Prostate
|
2006
|
1.11
|
|
9
|
Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia.
|
Carcinogenesis
|
2002
|
1.10
|
|
10
|
Evaluation of magnetic fluid hyperthermia in a standard rat model of prostate cancer.
|
J Endourol
|
2004
|
1.06
|
|
11
|
Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.
|
Prostate
|
2005
|
0.98
|
|
12
|
SV40 large T-antigen disturbs the formation of nuclear DNA-repair foci containing MRE11.
|
Oncogene
|
2002
|
0.98
|
|
13
|
Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.
|
Blood Cells Mol Dis
|
2005
|
0.93
|
|
14
|
Modification of aminosilanized superparamagnetic nanoparticles: feasibility of multimodal detection using 3T MRI, small animal PET, and fluorescence imaging.
|
Mol Imaging Biol
|
2009
|
0.89
|
|
15
|
Imaging of single human carcinoma cells in vitro using a clinical whole-body magnetic resonance scanner at 3.0 T.
|
Magn Reson Med
|
2005
|
0.86
|
|
16
|
Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
|
Int J Cancer
|
2002
|
0.84
|
|
17
|
Local arterial infusion of superparamagnetic iron oxide particles in hepatocellular carcinoma: A feasibility and 3.0 T MRI study.
|
Invest Radiol
|
2006
|
0.84
|
|
18
|
Hyperthermia classic commentary: 'Inductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia' by Andreas Jordan et al., International Journal of Hyperthermia, 1993;9:51-68.
|
Int J Hyperthermia
|
2009
|
0.83
|
|
19
|
[Thermal therapy of prostate cancer using magnetic nanoparticles].
|
Actas Urol Esp
|
2007
|
0.82
|
|
20
|
18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma.
|
Int J Hyperthermia
|
2006
|
0.81
|
|
21
|
A systematic proteomic study of irradiated DNA repair deficient Nbn-mice.
|
PLoS One
|
2009
|
0.78
|
|
22
|
Re: Lyndon Gommersall, Iqbal S. Shergill, Hashim U. Ahmed et al. Nanotechnology and its relevance to the urologist. Eur Urol 2007;52:368-75.
|
Eur Urol
|
2007
|
0.75
|
|
23
|
Iodinated nitroimidazoles as radiosensitizers.
|
Anticancer Res
|
2005
|
0.75
|